Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

CervoMed (CRVO) Interest & Investment Income (2022 - 2025)

CervoMed's Interest & Investment Income history spans 4 years, with the latest figure at $318787.0 for Q3 2025.

  • For Q3 2025, Interest & Investment Income fell 50.67% year-over-year to $318787.0; the TTM value through Sep 2025 reached $1.6 million, up 6.84%, while the annual FY2024 figure was $1.9 million, 782.94% up from the prior year.
  • Interest & Investment Income for Q3 2025 was $318787.0 at CervoMed, down from $368127.0 in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $678441.0 in Q2 2024 and bottomed at -$145671.0 in Q4 2022.
  • The 4-year median for Interest & Investment Income is $80633.0 (2024), against an average of $214119.4.
  • The largest annual shift saw Interest & Investment Income plummeted 68.03% in 2023 before it surged 3731.48% in 2024.
  • A 4-year view of Interest & Investment Income shows it stood at -$145671.0 in 2022, then soared by 181.45% to $118652.0 in 2023, then surged by 348.52% to $532181.0 in 2024, then plummeted by 40.1% to $318787.0 in 2025.
  • Per Business Quant, the three most recent readings for CRVO's Interest & Investment Income are $318787.0 (Q3 2025), $368127.0 (Q2 2025), and $408985.0 (Q1 2025).